Latest News about DXCM
Recent news which mentions DXCM
This investor crushes his fund’s benchmark with these 10 stocks
October 12, 2021
From MarketWatch
Got $1,000? These 2 High-Growth Stocks Are Screaming Buys Right Now
October 12, 2021
From Motley Fool
3 Innovative Growth Stocks That'll Make You Richer Through 2025
October 05, 2021
From Motley Fool
2 Unstoppable Stocks to Buy and Hold Forever
September 30, 2021
From Motley Fool
Ignore GameStop: Here Are 2 Better Stocks
September 28, 2021
From Motley Fool
Dexcom Insider Sold Over $3.87 Million In Company Stock
September 27, 2021
Tickers
DXCM
From Benzinga
Should You Take the "Basket Approach" to Investing in Tech Stocks?
September 24, 2021
From Motley Fool
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
Dexcom Insider Sold Over $3.24 Million In Company Stock
September 17, 2021
Tickers
DXCM
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
2 Sizzling Hot Stocks to Buy Right Now
September 15, 2021
From Motley Fool
Here's Why iRhythm Technologies Stock Is Making Big Gains Today
September 13, 2021
From Motley Fool
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
September 08, 2021
From Benzinga
3 Growth Stocks That'll Make You Richer By 2024
September 05, 2021
From Motley Fool
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
Senseonic Stock Is Climbing After Bouncing Back From a Disappointing Q2
September 02, 2021
From InvestorPlace
Moderna And DexCom Lead The Nasdaq-100
September 01, 2021
From Benzinga
There’s a Pullback Coming for Senseonics Stock, So Get Ready To Pounce
September 01, 2021
From InvestorPlace
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
Senseonics Can Move Higher, but Competitive Concerns Abound
August 25, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.